Apbidin P 0.15% Eye Drop

Gain a clear understanding of Apbidin P 0.15% Eye Drop, a product by Ajanta Pharma Ltd formulated with the salt combination Brimonidine (0.15% w/v). This medication is commonly used for Glaucoma,Ocular hypertension. Continue reading to explore comprehensive details about its application and other essential information to help you make informed decisions regarding your health needs.

MRP: ₹ 116.18
Packing: 5.0 ml in 1 packet
Salt Combination: Brimonidine (0.15% w/v)
Brand: Ajanta Pharma Ltd
Uses: Glaucoma,Ocular hypertension

Description

Apbidin P 0.15% Eye Drop is used in the treatment of ocular hypertension (pressure in the eye) and glaucoma
It helps to lower high pressure in the eye and reduces the risk of vision loss
This medicine may be used alone or in combination with another eye drop that reduces pressure in the eye
Apbidin P 0.15% Eye Drop is for external use only
Use it in the dose and duration as advised by the doctor
If you wear contact lenses, remove them before using the medication
Avoid touching the tip of the dropper to any surface as it may contaminate the eye drop
For best results, use it daily in the evening or at night.
The common side effects include allergic conjunctivitis, burning sensation, conjunctival inflammation, conjunctival hyperemia, eye itching, high blood pressure, allergic reaction in the eyes, dry mouth, and visual disturbance
If they persist or worsen, inform your doctor
If these side effects persist for a longer duration, please inform your doctor
Caution is advised for driving after administration of this injection if your eyes are not able to concentrate and react.

Cautions

Liver:	No interaction found/established
Kidney:	No interaction found/established
Driving:	UNSAFE: Apbidin P 0.15% Eye Drop may cause side effects which could affect your ability to drive.^Apbidin P 0.15% Eye Drop may cause blurred or abnormal vision. This effect may seem worse at night or in reduced lighting and this may affect the ability to drive.
Breast feeding:	CONSULT YOUR DOCTOR: Apbidin P 0.15% Eye Drop is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.^To reduce the amount of Apbidin P 0.15% Eye Drop that reaches the breastmilk, place pressure over the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.
Pregnency:	CONSULT YOUR DOCTOR: Apbidin P 0.15% Eye Drop may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Alcohol:	No interaction found/established
Drug Action:	Sympathomimetics- Ocular
Therapeutic class:	OPHTHAL
Habit Forming:	No
Chemical Class:	Quinoxaline Derivative

Uses of Apbidin P 0.15% Eye Drop

In Glaucoma Glaucoma is a group of eye conditions that damage the optic nerve, the health of which is vital for good vision
This damage is often caused by an abnormally high pressure in your eye
Glaucoma is one of the leading causes of blindness for people over the age of 60 or older
Apbidin P 0.15% Eye Drop is used to reduce swelling and pressure inside the eye
This helps to prevent complications of glaucoma such as blindness and improves the vision
In Ocular hypertension Ocular hypertension is a condition where the pressure inside the eye is higher than normal eye pressure
This may occur due to an injury, certain diseases or as an adverse effect of certain medications
Apbidin P 0.15% Eye Drop reduces the fluid accumulation of the eye and facilitates draining of the fluid from the eyes
This helps treat ocular hypertension and prevents further damage or complications such as vision changes or even vision loss.

Missed Doses

If you miss a dose of Apbidin P 0.15% Eye Drop, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

FAQs